ENSC: Ensysce Biosciences, Inc. Stock

by  •  • Comments Off on ENSC: Ensysce Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8.76
Enterprise Value ($M) 5.05
Book Value ($M) 6.58
Book Value / Share 5.04
Price / Book 1.33
NCAV ($M) 6.29
NCAV / Share 4.82
Price / NCAV 1.39

Profitability (mra)
Return on Invested Capital (ROIC) -1.08
Return on Assets (ROA) -2.92
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.24
Current Ratio 3.24

Balance Sheet (mrq) ($M)
Current Assets 9.09
Assets 9.38
Liabilities 2.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G Anson Funds Management LP 7.10
11-06 13G Ra Capital Management, L.p. 9.90
10-29 13G Perceptive Advisors Llc 8.70
02-14 13G/A Lincoln Park Capital Fund, LLC 3.79 -91.74

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 19,219 32,862 58.48
2025-01-30 7,254 18,952 38.28
2025-01-29 4,692 18,720 25.06
2025-01-28 3,616 22,000 16.44

(click for more detail)

Similar Companies
ELTX – Elicio Therapeutics, Inc. ELUT – Elutia Inc.
ENLV – Enlivex Therapeutics Ltd. ENTO – Entero Therapeutics, Inc.
ENTX – Entera Bio Ltd.


Financial data and stock pages provided by
Fintel.io